Compare AMRC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRC | CERT |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2010 | 2020 |
| Metric | AMRC | CERT |
|---|---|---|
| Price | $23.15 | $7.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $37.88 | $11.67 |
| AVG Volume (30 Days) | 669.9K | ★ 2.4M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,769,928,000.00 | $418,838,000.00 |
| Revenue This Year | $10.71 | $4.18 |
| Revenue Next Year | $9.07 | $5.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $18.38 | $4.45 |
| 52 Week High | $44.93 | $13.88 |
| Indicator | AMRC | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 54.73 |
| Support Level | $20.37 | $7.86 |
| Resistance Level | $23.96 | $8.39 |
| Average True Range (ATR) | 1.26 | 0.32 |
| MACD | -0.14 | -0.06 |
| Stochastic Oscillator | 27.70 | 34.31 |
Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.